Anesthesiology Doctors in Warwick, RI Accepting Medicare

6 Anesthesiology doctors found. Showing 1 - 6

Regis P Burlas, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1131 Warwick Ave, Warwick, RI 02888 Phone: 401-287-4440    Fax: 401-461-4791

Dr. Richard David Langfield, D.O. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010

Dr. Jean Paul Gottret, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 215-720-6095

Dr. Afreen Siddiqui, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 935 Jefferson Blvd, Suite 1002, Warwick, RI 02886 Phone: 401-490-7530    Fax: 401-490-7533

Dr. Manuel E Saborio, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 125 Squantum Dr, Warwick, RI 02888 Phone: 401-463-8537

David Michael Lareau, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Warwick, RI 02886 Phone: 401-737-7000

News Archive

Union reaches contract agreement with Minn. hospitals

Union workers have overwhelmingly ratified a new three-year contract that averted a strike at eight Twin Cities hospitals. The union represents 3,500 nursing assistants, technicians and support staff. The agreement was reached last week after union members voted to authorize a 2- to 5-day strike. The union says the new contract holds back on increases in health benefit premiums, retains overtime benefits and includes small wage increases.

Henry Schein third quarter net sales increases 14.1% to $1.9 billion

Henry Schein, Inc. the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 25, 2010.

Intarcia presents ITCA 650 Phase 2 study results at 70th ADA

Intarcia Therapeutics, Inc. presented today the results of a phase 2 clinical study of ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes as a late-breaker at the Annual Conference of the American Diabetes Association in Orlando, FL (June 25-29, 2010). Results of the phase 2 study demonstrated substantial reductions in HbA1c and body weight during the 12 weeks of treatment with ITCA 650 at both the 20 mcg/day and 40 mcg/day doses.

Researchers develop promising metal-based compound to fight kidney cancer

Researchers developed a promising metal-based compound that destroys kidney cancer cells, while leaving normal cells unharmed. The findings may provide a new way of treating kidney cancer, opening the potential for more potent and less toxic therapies that would give cancer patients a better quality of life.

Kidney transplantation may offer survival benefit for patients on long-term dialysis

A new study finds that kidney transplantation prolongs the lives of not only patients who have recently initiated dialysis, but also those who have been undergoing dialysis for more than a decade.

Read more Medical News

› Verified 9 days ago